These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 9186284)
21. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels. Leroux G; Lemieux I; Lamarche B; Cantin B; Dagenais GR; Lupien PJ; Després JP Metabolism; 2000 Jan; 49(1):53-61. PubMed ID: 10647064 [TBL] [Abstract][Full Text] [Related]
22. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients. Burrell D; Antignani A; Fein PA; Goldwasser P; Mittman N; Avram MM ASAIO Trans; 1990; 36(3):M331-5. PubMed ID: 2123635 [TBL] [Abstract][Full Text] [Related]
23. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
24. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863 [TBL] [Abstract][Full Text] [Related]
25. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054 [TBL] [Abstract][Full Text] [Related]
26. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783 [TBL] [Abstract][Full Text] [Related]
27. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure. Kimak E; Solski J Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828 [TBL] [Abstract][Full Text] [Related]
28. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474 [TBL] [Abstract][Full Text] [Related]
29. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561 [TBL] [Abstract][Full Text] [Related]
30. Plasma lipoproteins in patients with chronic renal failure (CRF). Kimak E; Solski J; Janicka L; Duma D; Zagojska M Int Urol Nephrol; 1997; 29(5):597-601. PubMed ID: 9413769 [TBL] [Abstract][Full Text] [Related]
31. Circadian variation of postprandial lipemia. Romon M; Le Fur C; Lebel P; Edmé JL; Fruchart JC; Dallongeville J Am J Clin Nutr; 1997 Apr; 65(4):934-40. PubMed ID: 9094875 [TBL] [Abstract][Full Text] [Related]
32. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318 [TBL] [Abstract][Full Text] [Related]
33. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf. Al-Rasadi K; Al-Zakwani I; Al Mahmeed W; Arafah M; Al-Hinai AT; Shehab A; Al Tamimi O; Alawadhi M Curr Med Res Opin; 2014 Dec; 30(12):2429-35. PubMed ID: 25222765 [TBL] [Abstract][Full Text] [Related]
35. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia. Bredie SJ; Westerveld HT; Knipscheer HC; de Bruin TW; Kastelein JJ; Stalenhoef AF Neth J Med; 1996 Aug; 49(2):59-67. PubMed ID: 8824106 [TBL] [Abstract][Full Text] [Related]
36. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482 [TBL] [Abstract][Full Text] [Related]
37. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794 [TBL] [Abstract][Full Text] [Related]